Literature DB >> 22806868

Improved synthesis of 2'-deoxyadenosine and 5-methyluridine by Escherichia coli using an auto-induction system.

Juan Xiong1, Wenquan Zhang, Jingtan Su, Junlong Shangguan, Yin Lin, Yang Yang, Rongqing Zhang, Liping Xie, Hongzhong Wang.   

Abstract

Nucleoside analogues are used widely for the treatment of viral diseases and cancer, however the preparation of some important intermediates of these nucleoside analogues, including 2'-deoxyadenosine (dAR) and 5-methyluridine (5-MU), remains inconvenient. To optimize the synthesis of dAR and 5-MU, recombinant strains and auto-induction medium were employed in this study. E. coli BL21(DE3) strains overexpressing purine nucleoside phosphorylase (PNP), uridine phosphorylase (UP) and thymidine phosphorylase (TP) were constructed and cultured in auto-induction ZYM-Fe-5052 medium for 8 h. The cultures of these strains were then used directly to synthesize dAR and 5-MU. Under optimized conditions, 30 mM adenine was converted to 29 mM dAR in 1 h, and 32 mM 5-MU was obtained from 60 mM thymine, using 6% (v/v) cell solutions as biocatalysts. These results indicate that our convenient and efficient method is ideal for the preparation of dAR and 5-MU, and has potential for the preparation of other nucleoside analogue intermediates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22806868     DOI: 10.1007/s11274-011-0868-2

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  11 in total

1.  Purification and characterization of a novel nucleoside phosphorylase from a Klebsiella sp. and its use in the enzymatic production of adenine arabinoside.

Authors:  F Ling; Y Inoue; A Kimura
Journal:  Appl Environ Microbiol       Date:  1990-12       Impact factor: 4.792

2.  Substrate specificity of Escherichia coli thymidine phosphorylase.

Authors:  N G Panova; C S Alexeev; A S Kuzmichov; E V Shcheveleva; S A Gavryushov; K M Polyakov; A M Kritzyn; S N Mikhailov; R S Esipov; A I Miroshnikov
Journal:  Biochemistry (Mosc)       Date:  2007-01       Impact factor: 2.487

3.  Enzymatic synthesis of 2'-deoxyadenosine and 6-methylpurine-2'-deoxyriboside by Escherichia coli DH5alpha overexpressing nucleoside phosphorylases from Escherichia coli BL21.

Authors:  Shenghua Liang; Wenzhou Li; Tong Gao; Xiangying Zhu; Guimei Yang; Daming Ren
Journal:  J Biosci Bioeng       Date:  2010-02-12       Impact factor: 2.894

Review 4.  Antisense oligonucleotides strategy in the treatment of hypertension.

Authors:  S Kagiyama; T Kagiyama; M I Phillips
Journal:  Curr Opin Mol Ther       Date:  2001-06

5.  Immobilization and stabilization of recombinant multimeric uridine and purine nucleoside phosphorylases from Bacillus subtilis.

Authors:  Silvia Rocchietti; Daniela Ubiali; Marco Terreni; Alessandra M Albertini; Roberto Fernández-Lafuente; José M Guisán; Massimo Pregnolato
Journal:  Biomacromolecules       Date:  2004 Nov-Dec       Impact factor: 6.988

Review 6.  Purine nucleoside phosphorylases: properties, functions, and clinical aspects.

Authors:  A Bzowska; E Kulikowska; D Shugar
Journal:  Pharmacol Ther       Date:  2000-12       Impact factor: 12.310

7.  Protein production by auto-induction in high density shaking cultures.

Authors:  F William Studier
Journal:  Protein Expr Purif       Date:  2005-05       Impact factor: 1.650

8.  [Synthesis of 2-chloro-2'-deoxyadenosine by microbiological transglycosylation using a recombinant Escherichia coli strain].

Authors:  S A Taran; K N Verevkina; T Z Esikova; S A Feofanov; A I Miroshnikov
Journal:  Prikl Biokhim Mikrobiol       Date:  2008 Mar-Apr

9.  Characterization of Escherichia coli uridine phosphorylase by single-site mutagenesis.

Authors:  Ilaria Oliva; Gabriele Zuffi; Dorianna Barile; Gaetano Orsini; Giancarlo Tonon; Luca De Gioia; Daniela Ghisotti
Journal:  J Biochem       Date:  2004-04       Impact factor: 3.387

10.  Co-expression of recombinant nucleoside phosphorylase from Escherichia coli and its application.

Authors:  Chongtao Ge; Liming OuYang; Qingbao Ding; Ling Ou
Journal:  Appl Biochem Biotechnol       Date:  2008-12-20       Impact factor: 2.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.